Journal article
Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group.
- Abstract:
-
AIMS: A detailed assessment of ophthalmic effects of an HMG CoA reductase inhibitor, simvastatin, was performed. METHODS: Six hundred and twenty one individuals considered to be at increased risk of coronary heart disease were randomised, following an 8 week placebo 'run in' period, to receive 40 mg daily simvastatin, 20 mg daily simvastatin, or matching placebo. Patients with a baseline corrected visual acuity better than 6/24 and without a history of cataract were eligible for detailed opht...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- British journal of ophthalmology
- Volume:
- 79
- Issue:
- 11
- Pages:
- 996-1002
- Publication date:
- 1995-11-01
- DOI:
- EISSN:
-
1468-2079
- ISSN:
-
0007-1161
- Source identifiers:
-
49375
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:49375
- UUID:
-
uuid:149eab64-57e2-4510-8db7-4cbe685199fa
- Local pid:
- pubs:49375
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 1995
If you are the owner of this record, you can report an update to it here: Report update to this record